{
    "2019-01-04": [
        [
            {
                "time": "",
                "original_text": "健帆生物: 发布第三个股权激励方案, 业绩考核指标不断提高",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "股权激励",
                        "业绩考核",
                        "提高"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "日本医疗器械行业深度研究之一: 整体篇",
                "features": {
                    "keywords": [
                        "日本",
                        "医疗器械",
                        "行业研究",
                        "整体篇"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗器械"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}